Skip to content Skip to main menu Skip to utility menu

Update: Pabrinex IV shortages

May 15, 2024

Please note that Pabrinex IV is now restricted to the following areas until further notice:

  • A&E (City and Sandwell)
  • AMU (City and Sandwell)
  • Critical Care (City and Sandwell)
  • Priory 2 ward
  • Priory 5 ward

All clinicians should continue to review any patients prescribed Pabrinex IV to ensure it is only being used within national clinical guidelines in terms of dose and length of course. The aim is to reduce the usage of Pabrinex IV and maintain stocks for essential use only.

For any questions, please contact the pharmacy team on ext. 5263 or 3783.